Citation Impact
Citing Papers
2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the Diagnosis and Management of Patients With Thoracic Aortic Disease
2010 Standout
Identification of a Primary Target of Thalidomide Teratogenicity
2010 StandoutScience
Thrombosis in vasculitis: from pathogenesis to treatment
2015
Optical coherence tomography angiography
2017 Standout
Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: recommendations of an expert panel
2000 Standout
A review of drug delivery systems based on nanotechnology and green chemistry: green nanomedicine
2017
Efficacy of the anti-IL 17 secukinumab in refractory Behçet's syndrome: A preliminary study
2018
Clinical translation of angiogenesis inhibitors
2002 Standout
Hidradenitis suppurativa: A comprehensive review
2009 Standout
Vasculitis in Behçet's Disease
1997
Successful treatment with Ipilimumab and Interleukin-2 in two patients with metastatic melanoma and systemic autoimmune disease
2014
Verteporfin PDT for non-standard indications—a review of current literature
2010
Familial Mediterranean Fever
2012 Standout
Updated consensus statement on biological agents, specifically tumour necrosis factor α (TNFα) blocking agents and interleukin-1 receptor antagonist (IL-1ra), for the treatment of rheumatic diseases, 2005
2005
Inflammatory bowel disease: clinical aspects and established and evolving therapies
2007 Standout
Diagnostic and treatment concerns in familial Mediterranean fever
2000
Long-term outcome after surgical treatment of arterial lesions in Behçet disease
2005
Thalidomide reduces tumour necrosis factor α and interleukin 12 production in patients with chronic active Crohn's disease
2002
Off-Label Dermatologic Uses of Anti-TNF-a Therapies
2005
Anti–tumor necrosis factor monoclonal antibody therapy for gastrointestinal Behçet's disease: A case report
2001
Nano based drug delivery systems: recent developments and future prospects
2018 Standout
Behcet's disease: from Hippocrates to the third millennium
2003
Cytokines and chemokines: At the crossroads of cell signalling and inflammatory disease
2014 Standout
Colchicine in clinical medicine. A guide for internists
2010
Autoinflammatory Diseases: Clinical and Genetic Advances
2008
Familial Mediterranean fever
1998
Inflammatory Bowel Disease
2002 Standout
Immunology and functional genomics of Beh�et's disease
2003
Etanercept treatment of cutaneous granulomas in common variable immunodeficiency
2006
Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2010
2011 Standout
Writing a narrative biomedical review: considerations for authors, peer reviewers, and editors
2011 Standout
Heat shock proteins and experimental autoimmune encephalomyelitis (EAE): I. Immunization with a peptide of the myelin protein 2?,3? cyclic nucleotide 3? phosphodiesterase that is cross-reactive with a heat shock protein alters the course of EAE
1996
Phase I study to determine the safety, tolerability and immunostimulatory activity of thalidomide analogue CC-5013 in patients with metastatic malignant melanoma and other advanced cancers
2004
TREATMENT OF CHOROIDAL NEOVASCULARIZATION DUE TO ANGIOID STREAKS
2013
An open-label pilot study of low-dose thalidomide in chronically active, steroid-dependent Crohn's disease
1999
Granulocytapheresis in patients with refractory ocular Behcet's disease
2006
Behçet's disease: a new target for anti-tumour necrosis factor treatment
2002
Behçet's syndrome
2008
Behçet's Disease
1999 Standout
Molecular Mechanisms of Amyloidosis
2003 Standout
The thalidomide saga
2007
2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline From the American Heart Association/American Stroke Association
2021 Standout
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue
2019 Standout
2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the Diagnosis and Management of Patients With Thoracic Aortic Disease
2010 Standout
European S1 guideline for the treatment of hidradenitis suppurativa/acne inversa
2015 Standout
Familial Mediterranean Fever (FMF) in Turkey
2005
ACC/AHA 2008 Guidelines for the Management of Adults With Congenital Heart Disease
2008 Standout
Ipilimumab plus Lenalidomide after Allogeneic and Autologous Stem Cell Transplantation for Patients with Lymphoid Malignancies
2017 StandoutNobel
ACC/AHA 2008 Guidelines for the Management of Adults With Congenital Heart Disease: Executive Summary
2008 Standout
IMMUNOLOGY OF MULTIPLE SCLEROSIS
2005 Standout
New photosensitizers for photodynamic therapy
2016 Standout
Anti-TNF therapy in the management of Behcet's disease--review and basis for recommendations
2007
Isolated Peripheral Pulmonary Artery Stenoses in the Adult
1996
Dysbiosis Contributes to Arthritis Development via Activation of Autoreactive T Cells in the Intestine
2016 StandoutNobel
TNF inhibitors – Mechanisms of action, approved and off-label indications
2014
Immune Checkpoint Blockade in Cancer Therapy
2015 Standout
Behcet’s Disease: Systemic and Ocular Manifestations
2013
Works of Cem Mat being referenced
Thalidomide in the Treatment of the Mucocutaneous Lesions of the Behcet Syndrome
1998
The Long-Term Mortality and Morbidity of Behçet Syndrome
2003
The HLA Association of Lepromatous Leprosy and Borderline Lepromatous Leprosy in Turkey
1988
Azathioprine in Behçet's syndrome. Effects on long‐term prognosis
1997
PULMONARY ARTERIAL ANEURYSMS IN BEHÇET'S SYNDROME: A REPORT OF 24 CASES
1994
Clinicopathologic Evaluation of Nodular Cutaneous Lesions of Behçet Syndrome
2001
Photodynamic therapy with verteporfin for choroidal neovascularization in patients with angioid streaks
2002
Histopathologic features of the spontaneous pustular lesions of Behçet’s syndrome
1998
Colloidal nanocarriers for the enhanced cutaneous delivery of naftifine: characterization studies and in vitro and in vivo evaluations
2016
THE TEN-YEAR MORTALITY IN BEHÇET'S SYNDROME
1996
A double-blind trial of colchicine in Beh�et's syndrome
2001
Behçet’s syndrome: Facts and controversies
2013
The frequency of scarring after genital ulcers in Behçet's syndrome: a prospective study
2006
A double-blind trial of depot corticosteroids in Behçet's syndrome
2005
Apremilast for Behçet’s Syndrome — A Phase 2, Placebo-Controlled Study
2015
Short-term trial of etanercept in Behçet's disease: a double blind, placebo controlled study.
2005
Vasculitis in familial Mediterranean fever.
1997